Bioinformatic analyses of published gene expression and DNA copy number studies of clinical breast tumors suggested that GINS2 was associated with the aggressive characteristics of a subgroup of breast cancers in vivo(11). This evidence concerns the gene GINS2 and breast neoplasm.